Melky Cabrera’s contract is not evidence that the drug program is broken

49 Comments

As soon as the news broke that Melky Cabrera is signing with the Blue Jays, several people in my Twitter timeline said things to the effect that it must be the case that baseball’s drug testing system is broken if someone fresh off a PED suspension can sign a two-year, $16 million deal. And I get the frustration I suppose, because no one likes to see cheaters prosper, but whatever you think of this deal, it cannot reasonably be interpreted as an indictment of the drug testing system.

Based on his last two seasons, Melky Cabrera was poised to make something like $40 million bucks in free agency. Maybe more. And now, though he is not going to be hurting or anything, he’s going to make less than half that.  Say what you want about the drug testing system, but tens of millions of dollars in lost wages is no small penalty.

Now, that doesn’t mean that Cabrera’s use of PEDs didn’t still somehow help him. I’ll acknowledge that $16 million over two years may still be more than he ever could have got if he never took PEDs.  But we don’t know. We simply have no way of knowing how much of Cabrera’s improvement over the past two years was a function of PEDs and how much of it was natural improvement as he reached an age when most players put up their best years. Maybe he would have turned into the player his potential always suggested he might, in which case he’d still be making a good living. Maybe he wouldn’t have. If anyone claims to know this for sure, they’re making crap up, because it’s unknowable with current science and baseball analytics.

But no matter what amount of advantage he still realized, it’s on Cabrera, human nature and the incentives any person — and any team like the Blue Jays — is subject to, not baseball’s drug program.  Just as no laws, no matter how tough, can eradicate crime, no drug testing program can eradicate cheating. People will still do it from time to time. And when they do, they run the risk of getting caught. And when they get caught, they are punished. As Melky Cabrera was punished, to the tune of tens of millions of dollars.

Still not good enough for you? OK, that’s your right to think so. But know that the only logical conclusion to such thinking is to advocate for a lifetime ban for first time drug users. Because that’s the only thing that would have kept a team from taking a chance on Melky Cabrera like the Blue Jays are.  And while you may disagree, I think such a thing would be way too damn harsh.

Video: Mets execute a bizarre double play against the Nationals

Getty Images
Leave a comment

Double plays come in an assortment of combinations, from the standard 6-4-3 combo to some more unusual patterns. During the Mets’ 5-3 win over the Nationals on Saturday, however, what made this double play strange was less the product of an unorthodox route and almost entirely due to an unexpected collision on the basepaths instead.

In the bottom of the fourth inning, with the Mets trailing 1-0, Zack Wheeler caught Jose Lobaton swinging for strike three. Mets’ backstop Travis d'Arnaud fired the ball to second base, where the ball slipped out of Asdrubal Cabrera‘s glove as Jayson Werth slid into the bag for a stolen base. Second baseman Neil Walker fielded the ball in shallow center field, then tossed it to third base, and Jose Reyes tagged Werth easily for the second out of the play.

The Mets complimented their defensive efforts with a strong showing at the plate, reclaiming the lead with three home runs from Michael Conforto and Jose Reyes to clinch their tenth win of the year.

Report: Adam Eaton to miss rest of the season with a torn ACL

Getty Images
3 Comments

It’s been a miserable weekend for Nationals’ outfielder Adam Eaton, who stumbled over first base and injured his leg while running out an infield single in Friday’s 7-5 loss to the Mets. While the team officially placed the outfielder on the 10-day disabled list with a left knee strain on Saturday, FOX Sports’ Ken Rosenthal reports that Eaton has been diagnosed with a torn ACL in his left knee and is expected to miss the remainder of the 2017 season. The team has yet to confirm the diagnosis or announce a definite timetable for the 28-year-old’s return, perhaps due to extended evaluations by Eaton’s orthopedic doctor:

The Nationals appear to have several outfield options with Eaton on the disabled list, though they have not pinned down a long-term solution. Center fielder Michael Taylor replaced Eaton on the field during the tail end of Friday’s game, and returned on Saturday to man center and bat second in the lineup. The club also promoted top outfield prospect Rafael Bautista, who slashed .291/.325/.354 with five doubles and a .680 OPS through 19 games in Triple-A Syracuse this season. He’ll assume Eaton’s roster spot and looks to be available for a backup role in the outfield going forward.